Breast Cancer Clinical Trial

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Summary

The purpose of this study is learn more about how being treated for breast cancer affects patients' employment. Researchers are testing an early version of a mobile app designed to help breast cancer patients keep their jobs during and after treatment. The app provides advice for patients to use when having conversations about breast cancer with their employers and their doctors. The app is called TEAMWork (Talking to Employers And Medical staff about Work). In this study, the investigators are asking breast cancer patients who are about to receive treatment or who are currently receiving treatment to tell us what aspects of the app work well, so that they can learn how to improve it.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patient Usability Testing Inclusion Criteria:

History of a cancer diagnosis
At least 18 years of age
Male or Female
The ability to give informed consent in English or Spanish
Able to use and read a smartphone (iPhone or Android)
Has a smartphone (iPhone or Android)

Community Usability Testing Inclusion Criteria:

At least 18 years of age
Male or Female
The ability to give informed consent in English or Spanish
Able to use and read a smartphone (iPhone or Android)
Has a smartphone (iPhone or Android)

Focus Group and Interview Inclusion Criteria:

Completed chemotherapy treatment for stage I-III breast cancer.
Age 18 to 64 (inclusive)
Female
Paid employment (full time or part time) in the three months prior to diagnosis or at time of consent to MSK protocol #10-071 (PI: Blinder)
The ability to give informed consent in English or Spanish
Able to use and read a smartphone (iPhone or Android)
Has a smartphone (iPhone or Android)

For Cohort 2:

Participants was covered by Emergency Medicaid at the time of diagnosis and/or at any point during their treatment for breast cancer

RCT Inclusion Criteria:

Localized invasive breast cancer (not stage 0 or stage IV)

If electronic medical record does not specify stage and patient is undergoing (neo)adjuvant chemotherapy, assume stage is I, II or III
Planning to undergo or undergoing adjuvant or neoadjuvant chemotherapy
Age 18 to 64 (inclusive)
Female
Employment statue of (full time or part time) (those who are on disability leave/medical leave, and other unique employment circumstances at the PI's dicretion are eligible)
Language preference as English or Spanish
Able to use and read a smartphone or tablet (e.g. iPad, iPhone or Android)
Has access to a smartphone or tablet (e.g. iPad, iPhone or Android)

Exclusion Criteria:

RCT Exclusion Criteria:

Stage 0 breast cancer (DCIS only)
Stage IV (metastatic) breast cancer
Recurrence with metastases of breast cancer
Participants or family members who are participating in MSK IHCD studies related to social determinants of health

Study is for people with:

Breast Cancer

Estimated Enrollment:

546

Study ID:

NCT03572374

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memoral Sloan Kettering Basking Ridge (Consent and Follow-up)
Basking Ridge New Jersey, 07920, United States More Info
Victoria Blinder, M.D., M.Sc
Contact
646-888-4808
Memorial Sloan Kettering Monmouth (Consent and Follow-up)
Middletown New Jersey, 07748, United States More Info
Victoria Blinder, MD, MSc
Contact
646-888-4808
Memorial Sloan Kettering Bergen (Consent and Follow up)
Montvale New Jersey, 07645, United States More Info
Victoria Blinder, M.D., M.Sc.
Contact
646-888-4808
Lincoln Medical and Mental Health Center
Bronx New York, 10451, United States More Info
Monica Muppidi, MD
Contact
718-579-5874
Montefiore Medical Center
Bronx New York, 10467, United States More Info
Della Makower, MD
Contact
718-862-8840
Memorial Sloan Kettering Westchester (Consent and Follow-up)
Harrison New York, 10604, United States More Info
Victoria Blinder, M.D., M.Sc
Contact
646-888-4808
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
Victoria Blinder, M.D., M.Sc
Contact
646-888-4808
Francesca Gany, M.D., M.Sc
Contact
646-888-8054

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

546

Study ID:

NCT03572374

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.